At-a-Glance
Key Takeaways with Craig
US Equity Indexes sold off again today and, once again, the Nasdaq led losses, down by over 1.5% today. Unsurprisingly, implied volatility in CME’s Equity Index options rose today and is now trading above the 6-month average closing level in the E-mini S&P 500 and Nasdaq-100 options.
CME Interest Rate markets stole the show though as the Micro 5, 10 and 30-Year Treasury Yield futures were all up by 14-15 basis points. The on-the-run US 10-Year Treasury yield is now trading at the highest level since 2007. The Micro 2-Year Treasury Yield future, however, was near steady on the day, arrowing the inversion between the 2s and 10s to about 60 basis points. Even though we’ve written about it several times, we thought the further diversion in skew between the 10 and 30-Year options and the 2-Year options was worth illustrating again. As you can see in the CVOL graph below, the 2-Year options are trading with a clear Put skew while the 10 and 30-Year are trading with a Call skew. Remember, these are in yield, not price terms.
Perhaps correlated with the higher Treasury yields, most major currencies were lower against the US Dollar in CME’s FX futures markets and Gold futures prices were down by almost 5%. CVOL in CME’s FX options markets rose with with the price moves, while that in the Gold options fell.
Todays Featured Videos
Today's Future Price Action
Traders Resources
The information in the market commentaries have been obtained from sources believed to be reliable, but we do not guarantee its accuracy and expressly disclaim all liability. Neither the information nor any opinions expressed therein constitutes a solicitation of the purchase or sale of any futures or options contracts. The information on this site compiled by CME Group is for general purposes only. All information and data herein is provided as-is. Additionally, all examples on this site are hypothetical situations, used for explanation purposes only, and should not be considered investment advice or the results of actual market experience. CME Group assumes no responsibility for any errors or omissions. CME Group, its affiliates and any third party information and content providers expressly disclaim all liability with respect to the information and data contained herein including without limitation, any liability with respect to the accuracy or completeness of any data. You use the data herein solely at your own risk. All data and information provided herein is not intended for trading purposes or for trading advice. All matters pertaining to rules and specifications herein are made subject to and superseded by official CME, CBOT, NYMEX and COMEX rules. Current rules should be consulted in all cases concerning contract specifications.
Neither futures trading nor swaps trading are suitable for all investors, and each involves the risk of loss. Due to the leveraged nature of futures trading and swaps trading, it is possible to lose more than the amount deposited in a position. Therefore, traders should not deposit more funds than they can afford to lose without negatively affecting their lifestyles. A trader cannot expect to profit on each trade, and should only devote a small amount of their available funds to each trade. All references to options refer to options on futures.
Past performance is not necessarily indicative of future performance.
CME Group, the Globe Logo, Chicago Mercantile Exchange, Globex and CME are trademarks of Chicago Mercantile Exchange Inc. CBOT is the trademark of the Board of Trade of the City of Chicago, Inc. NYMEX is the trademark of the New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. All other marks are the property of their respective owners. Each of Chicago Mercantile Exchange Inc. (ARBN 103 432 391), The Board of Trade of the City of Chicago Inc (ARBN 110 594 459), the New York Mercantile Exchange Inc (ARBN 113 929 436) and Commodity Exchange, Inc. (ARBN 622 016 193) is a registered foreign company in Australia and holds an Australian market licence.
This site does not constitute a prospectus, product disclosure statement or legal advice, nor is it a recommendation to buy, sell or retain any specific investment or to utilise or refrain from utilising any particular service. Readers should consult their legal advisors for legal advice in connection with the matters covered on this site.
